Skip to content

Exor N.V.

Follow

13F filer, CIK 1589122, Amsterdam, Netherlands

Exor N.V. reported $26,596,246,650 across 7 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13.

Accepted , ingested 13F-HR 0001193125-26-459439

Period
2026-09-30
Reported value
$26.6B
Holdings
7
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001193125-26-459439, largest first. % of portfolio is the value over $26,596,246,650, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RACEFERRARI N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 44,435,280 shares; 2025Q1: 37,768,613 shares; 2025Q2: 37,768,613 shares; 2025Q3: 37,768,613 shares; 2025Q4: 37,768,613 shares; 2026Q1: 37,768,613 shares; 2026Q2: 37,768,613 shares; 2026Q3: 37,768,613 shares 37,768,613$14.8B55.79%0Timeline
CNHCNH INDL N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 366,927,900 shares; 2025Q1: 366,927,900 shares; 2025Q2: 366,927,900 shares; 2025Q3: 366,927,900 shares; 2025Q4: 366,927,900 shares; 2026Q1: 366,927,900 shares; 2026Q2: 366,927,900 shares; 2026Q3: 366,927,900 shares 366,927,900$4.72B17.73%0Timeline
00Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 164,553,857 shares; 2025Q1: 172,779,520 shares; 2025Q2: 182,543,970 shares; 2025Q3: 182,543,970 shares; 2025Q4: 182,543,970 shares; 2026Q1: 182,543,970 shares; 2026Q2: 185,932,684 shares; 2026Q3: 185,932,684 shares 185,932,684$4.54B17.08%0
STLASTELLANTIS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 449,410,092 shares; 2025Q1: 449,410,092 shares; 2025Q2: 449,410,092 shares; 2025Q3: 449,410,092 shares; 2025Q4: 449,410,092 shares; 2026Q1: 449,410,092 shares; 2026Q2: 449,410,092 shares; 2026Q3: 449,410,092 shares 449,410,092$1.96B7.37%0Timeline
VIAVIA TRANSN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,121,131 shares; 2025Q4: 14,121,131 shares; 2026Q1: 14,121,131 shares; 2026Q2: 14,121,131 shares; 2026Q3: 14,121,131 shares 14,121,131$427M1.61%0Timeline
CLVTCLARIVATE PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 67,294,884 shares; 2025Q1: 67,294,884 shares; 2025Q2: 67,294,884 shares; 2025Q3: 67,294,884 shares; 2025Q4: 67,294,884 shares; 2026Q1: 67,294,884 shares; 2026Q2: 67,294,884 shares; 2026Q3: 67,294,884 shares 67,294,884$112M0.42%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,215,662 shares; 2025Q1: 4,215,662 shares; 2025Q2: 4,215,662 shares; 2025Q3: 4,215,662 shares; 2025Q4: 4,215,662 shares; 2026Q1: 4,215,662 shares; 2026Q2: 4,215,662 shares; 2026Q3: 4,215,662 shares 4,215,662$2.51M0.01%0Timeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-459439 base2026-11-13